Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05929898

MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants

The purpose of this research study is to understand how healthy individuals self-regulate motivation by observing brain activity using magnetic resonance imaging (MRI).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Neuromodulatory nuclei detect and transform brain network activity into simpler signals, then send neurotransmitters back out to large-scale brain networks to change their function. Such nuclei are centrally implicated in mental disorders and adaptive resilience, and their regulation remains an untapped resource for interventions. The purpose of this study is to understand how neuromodulatory nuclei detect and in turn influence distributed patterns of brain activity to impact behavior. In order to understand their regulation and effects on brain function, the investigative team has developed novel neuroimaging, behavioral, and analytic methods. These methods include: training participants to endogenously self-regulate dopaminergic midbrain and then relating midbrain activation to memory-conducive states, effort exertion, and decision making.

If the aims of this project are achieved, the investigators will have methods for regulating midbrain noninvasively, an improved understanding of its impact on learning and motivated behavior, and reliable cognitive strategies for a wide array of interventions across educational and clinical applications.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 45 years
  • Right-handed
  • In good general health

Exclusion criteria

  • Current or diagnosis within past six months of an DSM-V Axis I or Axis II disorder (self-reported)
  • CES-D score of 20 or higher (indicating significant current depression symptoms)
  • Current or past six month use of prescription medications indicated for psychiatric conditions (e.g.,depression, anxiety)
  • Current serious medical illness (self-reported)
  • Head injury resulting in loss of consciousness
  • For participants age > 59 years, a total scaled score < 8 on the Dementia Rating Scale-2.
  • A clinically-defined neurological disorder including, but not limited to:
  • Any condition likely to be associated with increased intracranial pressure
  • Space occupying brain lesion
  • History of stroke
  • Transient ischemic attack within two years
  • Cerebral aneurysm
  • Dementia
  • Mini Mental Status Exam (MMSE) score of <24
  • Parkinson's disease
  • Huntington's disease
  • Multiple sclerosis
  • Presence of cochlear implants or other implanted electronic devices or non-removable metal (e.g., non-removable piercing, IUD)
  • History of an eye injury involving metal. Participants who worked with metal may be allowed to participate on a case-by-case basis with prior written approval from BIAC.
  • Claustrophobia or unwillingness to tolerate the confinement associated with being in the MRI scanner.
  • Weight of more than 250 pounds

Treatment and study plan

Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback

Behavioral

fMRI neurofeedback training of sustained midbrain/VTA activation via motivational imagery.

Primary outcomes

  1. Percent signal change in VTA BOLD activation

    Time frame: During the MRI scan, approximately 2 hours

Secondary outcomes

  1. Change in effort-based decision making, as measured by the Effort Expenditure for Reward Task (EEfRT)

    Time frame: During the MRI scan, approximately 2 hours

    Decisions to exert effort.

  2. Change in motivated memory, as measured by the Monetary Incentive Encoding task (MIE)

    Time frame: During the MRI scan, approximately 2 hours

    Improved motivated memory formation.

Study contacts

Contact information is provided by the study sponsor or research team.

Alannah Rivera-Cancel, BA

CONTACT

[email protected]

919-385-0836

R. Alison Adock, MD, PhD

CONTACT

[email protected]

919-681-4601

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Official study title

Bridging Scales to Understand Endogenous Neuromodulation and Its Regulation

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 3, 2023
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.